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Immune response and metabolic regulation are highly integrated
and this interface maintains a central homeostatic system, dys-
function of which can cause obesity-associated metabolic disorder
such as type 2 diabetes, fatty liver disease, and cardiovascular
disease. Insulin resistance is an underlying basis for the patho-
genesis of these metabolic diseases. Overnutrition or obesity
activates the innate immune system with subsequent recruit-
ment of immune cells such as macrophages and T cells, which
contributes to the development of insulin resistance. In par-
ticular, a significant advance in our understanding of obesity-
associated inflammation and insulin resistance has been recogni-
tion of the critical role of adipose tissue macrophages (ATMs).
ATMs are a prominent source of proinflammatory cytokines,
such as TNF-α and IL-6, that can block insulin action in adi-
pose tissue, skeletal muscle, and liver autocrine/paracrine signaling
and cause systemic insulin resistance via endocrine signaling,
providing a potential link between inflammation and insulin
resistance.
All articles in this topic highlight the interconnection between
obesity, inflammation, and insulin resistance in all its diversity
to the mechanisms of obesity-induced inflammation and role of
immune system in the pathogenesis of insulin resistance and dia-
betes. These articles give some insight into unanswered questions
in relation to this topic. First, the relationship between nutrient
sensing systems and the interface of metabolic and inflammatory
responses is complex. Pattern-recognition receptors (PRRs) such
as Toll-like receptors (TLR) and the receptor for advanced gly-
cation end-products (RAGE) are activated in response to dietary
nutrients and changes of gut microbiota as described in the review
articles by Tanti et al. and Yamamoto et al. (1, 2). The activa-
tion of PRRs plays a crucial role as a trigger of this metabolic
inflammation. Retinoic acid-related orphan receptors RORα and
RORγ, also provide an important link between the circadian clock
machinery and its regulation of metabolic genes (3). Two stud-
ies by Moustaid-Moussa et al. show a potential role of the renin
angiotensin system in the development of insulin resistance and
diabetes by using gain and loss of function in mice (4, 5). Second,
it is not clear which cell recruits and activates or which tissue
inflammation initially occurs upon obesity, which then causes
systemic inflammation and subsequent development of insulin
resistance. McArdle et al. and Tateya et al. describe how obesity
causes alteration of the immune cells, in which TH1 cells, B cells,
neutrophils, or mast cells induce M1 activation and polarization
of macrophages by the elevated secretion of TNFα and IFNγ (6, 7).
In addition to proinflammatory cytokines and adipokines, more
metabolic regulators including fibroblast growth factor (FGF)
family such as FGF 21 and FGF19 and bioactive lipids, sphin-
golipids can contribute to the development of systemic inflam-
mation and subsequent development of insulin resistance (8, 9).
Interestingly, these novel adipokines can be dramatically changed
after bariatric surgery and these changes contribute to improve-
ment of obesity-associated inflammation, insulin resistance, and
glucose homeostasis (10).
Overall, all the original articles and review articles covering
this topic in all its diversity to contribute somewhat to clar-
ify unanswered questions on the mechanisms of obesity-induced
inflammation and insulin resistance.
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